SiteWatch: MUSC Hollings Cancer Center Featured Clinical Trials

Dec 12, 2018 | Leading Sites, Medical University of South Carolina, Oncology, Site Success, Site Watch

cancer trial

Medical University of South Carolina (MUSC), a NCI-designated Cancer Center strives to bring its patients cutting edge cancer treatment options. They recently provided a link to featured trials available at the center.  Select the link below to review the showcased clinical trials. MUSC, founded in 1824, The Medical University of South Carolina (MUSC) continues the tradition of excellence in education, research and patient care. MUSC educates and trains more than 3,000 students and 700 residents in six colleges and has nearly 13,000 employees, including approximately 1,500 faculty members. As the state’s only academic health science center and largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $2.4 billion, with an annual economic impact of nearly $4 billion and annual research funding in excess of $250 million. MUSC operates a 700-bed medical center, which includes a nationally recognized children’s hospital, the NCI-designated Hollings Cancer Center, a Level I trauma center, Institute of Psychiatry, more than 100 outreach locations across the state, and South Carolina’s only transplant center.

0 Comments

Pin It on Pinterest